Cationic Lipid Nucleic Acid Delivery Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cationic lipids do not efficiently introduce nucleic acids into cells, limiting the development of nucleic acid medicines with high pharmacological efficacy and safety.
Innovation Solution
A compound represented by a specific formula, or its salt, is used to form lipid particles or compositions that facilitate the efficient introduction of nucleic acids into various cells, tissues, or organs, including the liver, cancer cells, adipose tissue, and bone marrow cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional cationic lipids are used to form complexes with nucleic acids, then the nucleic acids can be introduced into cells, but the introduction efficiency is insufficient and pharmacological efficacy is limited
Solution Approach 1:
The patent modifies the chemical structure of cationic lipids by changing parameters such as the hydrocarbon chain length, head group composition, and charge density. Specifically, the invention uses cationic lipids with quarternary ammonium groups and specific fatty acid chains (e.g., C12-C18) to optimize both transfection efficiency and cellular uptake, thereby simultaneously improving introduction efficiency and pharmacological efficacy.
Solution Approach 2:
The patent employs composite lipid formulations combining multiple cationic lipid components with complementary properties. The composite structure includes cationic lipids for complex formation, helper lipids for membrane interaction, and cholesterol for stability, creating a synergistic system that enhances both nucleic acid delivery efficiency and pharmacological effectiveness.
2Adaptability or versatility
If cationic lipids are used for nucleic acid delivery, then cells can be targeted, but toxicity remains a concern limiting safety
Solution Approach 1:
The patent introduces PEGylated lipid components into the cationic lipid formulation, creating regions with different properties within the same particle. The PEGylated portions provide steric stabilization and reduced immunogenicity at the particle surface, while the cationic core maintains nucleic acid binding and cellular targeting capabilities, thereby reducing toxicity while preserving cell targeting.
Solution Approach 2:
The patent utilizes the inherent toxicity mechanism of cationic lipids by optimizing their structure to achieve selective toxicity against target cells while minimizing damage to healthy cells. The modified cationic lipids with specific chain lengths and head groups exhibit enhanced selectivity for diseased cells, converting the potentially harmful toxic effect into a beneficial therapeutic selectivity.
3Productivity
If existing cationic lipid formulations are used, then nucleic acid delivery is possible, but the range of applicable cell types and tissues is limited
Solution Approach 1:
The patent develops cationic lipid formulations with universal applicability across multiple cell types and tissues by optimizing the lipid structure to interact with common cellular components. The use of quarternary ammonium groups and specific hydrocarbon chains enables the formulation to effectively deliver nucleic acids to diverse cells including hepatocytes, adipocytes, and bone marrow cells, achieving broad tissue applicability while maintaining high delivery efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound enables high-efficiency introduction of nucleic acids into cells, achieving effective pharmacological expression and providing a stable, low-toxicity delivery method for various cell types and tissues.
Implementation Method 1
a technology introducing nucleic acids into cells after mixing the nucleic acid and lipids to form a complex via said complex
Data Source
AI summary
The present invention provides a technology which enables introduction of an active ingredient (e.g. nucleic acids) into various cells with a high efficiency, and compounds used therefor. The present invention provides a compound represented by the formula: [wherein, each symbol is as defined in the present description] or a salt thereof.